Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ana Leda, Longhini"'
Autor:
Juliana Xavier-Ferrucio, Lauremília Ricon, Karla Vieira, Ana Leda Longhini, Mariana Lazarini, Carolina Louzão Bigarella, Gilberto Franchi, Jr, Diane S. Krause, Sara T.O. Saad
Publikováno v:
Stem Cell Research, Vol 26, Iss , Pp 17-27 (2018)
Arhgap21 is a member of the Rho GTPase activating protein (RhoGAP) family, which function as negative regulators of Rho GTPases. Arhgap21 has been implicated in adhesion and migration of cancer cells. However, the role of Arhgap21 has never been inve
Externí odkaz:
https://doaj.org/article/0f2e0196dd0f4dcfaa7f9fdaecb6be83
Autor:
Rita de Cássia Carvalho Melo, Ana Leda Longhini, Carolina Louzão Bigarella, Mariana Ozello Baratti, Fabiola Traina, Patrícia Favaro, Paula de Melo Campos, Sara Teresinha Olalla Saad
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e85926 (2014)
Recently, a novel CXCL12-binding receptor, has been identified. This CXCL12-binding receptor commonly known as CXCR7 (CXC chemokine receptor 7), has lately, based on a novel nomenclature, has received the name ACKR3 (atypical chemokine receptor 3). I
Externí odkaz:
https://doaj.org/article/6c0de6e62b8e470eb9892ebc91c1fa33
Autor:
Fernanda Marconi, Roversi, Fernando Vieira, Pericole, João Agostinho, Machado-Neto, Adriana, da Silva Santos Duarte, Ana Leda, Longhini, Flávia Adolfo, Corrocher, Bruna, Palodetto, Karla Priscila, Ferro, Renata Giardini, Rosa, Mariana Ozello, Baratti, Sergio, Verjovski-Almeida, Fabiola, Traina, Alessio, Molinari, Maurizio, Botta, Sara Teresinha Olalla, Saad
Publikováno v:
Biochimica et biophysica acta. Molecular basis of disease. 1863(2)
New drug development for neoplasm treatment is nowadays based on molecular targets that participate in the disease pathogenesis and tumor phenotype. Herein, we describe a new specific pharmacological hematopoietic cell kinase (HCK) inhibitor (iHCK-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ad9b07f1429d92ab41f4c827673c6a65
https://pubmed.ncbi.nlm.nih.gov/27840303
https://pubmed.ncbi.nlm.nih.gov/27840303
Autor:
Fernanda Marconi Roversi, Matheus Rodrigues Lopes, João Agostinho Machado-Neto, Ana Leda Longhini, Adriana da Silva Santos Duarte, Bruna Palodetto, Flavia Adolfo Corrocher, Paula de Melo Campos, Mariana Ozello Baratti, Fernando V Pericole, Patricia Favaro, Fabiola Traina, Sara Teresinha Saad
Publikováno v:
Blood. 122:2763-2763
Myelodysplastic syndromes (MDS) are clonal disorders of hematopoietic stem cells (HSC) characterized by ineffective hematopoiesis. In addition to HSC defects, an important role is also played by the hematopoietic microenvironment niche that has as ke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b194a9c36738dd2500c1436ebac3b36a
https://doi.org/10.1182/blood.v122.21.2763.2763
https://doi.org/10.1182/blood.v122.21.2763.2763
Autor:
Xavier, Juliana M. *, Lauremília, Ricon *, Karla, Vieira *, Ana Leda, Longhini *, Gilberto, Franchi, Jr *, Alexandre, Nowill *, Bigarella, Carolina *, Saad, Sara T.O
Publikováno v:
In Blood 6 December 2014 124(21):4333-4333
Autor:
Xavier, Juliana M. *, Ricon, Lauremilia *, Vieira, Karla Priscila *, Ana Leda, Longhini *, Bigarella, Carolina *, Franchi, Gilberto C, Jr *, Saad, Sara T O
Publikováno v:
In Blood 6 December 2014 124(21):1591-1591